Sandler Laura Lee
SEC CIK 2075401 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | COO | 235.5K | — | $1.94M | 14 | 2026-01-02 | 2026-09-15 |
Most active insiders at ORKA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| 2 | Dambkowski Carl | Dir | — | $8.65M |
| 3 | Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| 4 | Quinlan Paul T | GC | — | $6.76M |
| 5 | Goncalves Joana | Chief Medical Off | — | $4.54M |
| 6 | Agarwal Arjun | SVP, Fin | — | $4.33M |
| 7 | Sandler Laura Lee | COO | — | $1.94M |
| 8 | Edwards Larry Todd | Chief Commercial Off | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 19:11 | 2026-09-15 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale | $95.71 | -906 | 235.5K | -0.4% | -$86.7K | |
| DT | 2026-09-01 18:36 | 2026-09-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 241.4K | +2% | +$39.0K |
| DMT | 2026-09-01 18:36 | 2026-09-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $91.82 | -5,000 | 236.4K | -2% | -$459.1K |
| DT | 2026-07-01 19:58 | 2026-07-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 241.4K | +2% | +$39.0K |
| DMT | 2026-07-01 19:58 | 2026-07-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $94.42 | -5,000 | 236.4K | -2% | -$472.1K |
| 2026-06-15 18:51 | 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale | $69.69 | -600 | 236.4K | -0.3% | -$41.8K | |
| DT | 2026-05-01 18:25 | 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 242.0K | +2% | +$39.0K |
| DMT | 2026-05-01 18:25 | 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $63.88 | -5,000 | 237.0K | -2% | -$319.4K |
| 2026-03-17 | 2026-03-16 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale | $41.30 | -600 | 237.0K | -0.3% | -$24.8K | |
| D | 2026-03-02 | 2026-03-02 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 242.6K | +2% | +$39.0K |
| DM | 2026-03-02 | 2026-03-02 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $33.56 | -5,000 | 237.6K | -2% | -$167.8K |
| D | 2026-01-23 | 2026-01-23 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | A - Grant | $0.00 | +32.5K | 237.6K | +16% | $0 |
| D | 2026-01-02 | 2026-01-02 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 218.1K | +2% | +$39.0K |
| DM | 2026-01-02 | 2026-01-02 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $28.52 | -13.0K | 205.1K | -6% | -$370.8K |
Purchase Sale Sale after option exercise All abbreviations